To compare the efficacy of 5 % vs. 1.25 % povidone-iodine (PI) as preoperative antiseptic prior to strabismus surgery in children as a prophylaxis of endophthalmitis. Given the low rate of endophthalmitis the conjunctival bacterial flora rate is…
ID
Source
Brief title
Condition
- Ocular neuromuscular disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The difference in the mean numbers of bacterial colony forming units (CFUs)
from pre-irrigation (l) to post-irrigation with PI (2-4).
Secondary outcome
Iodine excretion after surgery, assessed as urine iodine concentration per
creatinine clearance.
Postoperative erosion of the cornea and corneal oedema. Both of these have been
described as side-effects of PI use.
Background summary
Endophthalmitis after strabismus surgery in young children leads to blindness
and loss of the affected eye. It is caused by conjunctival bacteria. PI
solutions between 1% and 5% reduce the number of bacteria on the conjunctiva.
The concentration used varies widely among clinics, from 1% to 5%. In vitro
studies have shown that PI is paradoxically more effective at lower
concentration, but in cataract surgery in elderly, 1% PI has been shown to be
less effective than 5% PI. Dilution by tear fluid or binding of PI to proteins
in tear fluid may lower its effectiveness. Since endophthalmitis after
strabismus surgery especially affects young children and the bacterial flora of
the conjunctiva in children is different from that in adults, the cataract PI
study should be repeated in young children operated for strabismus.
Study objective
To compare the efficacy of 5 % vs. 1.25 % povidone-iodine (PI) as preoperative
antiseptic prior to strabismus surgery in children as a prophylaxis of
endophthalmitis. Given the low rate of endophthalmitis the conjunctival
bacterial flora rate is used as surrogate marker to determine the effectiveness
of topical PI in reducing or eliminating bacteria from the ocular surface at
the time of the surgery.
Study design
The study is a multi-centre, prospective, randomized-controlled,
parallel-groups, assessor-blind (microbiological assessments),
investigator-initiated trial.
Intervention
Diluted PI, 1.25% or 5%, will be prepared in a sterile fashion, and distributed
in single-use dispensers. These will be coded for randomization. Before
initiation of surgery, children randomized to the 5% PI group will have their
conjunctival fornices irrigated with 5 ml PI 5%. Children randomized to the
1.25% PI group will have their conjunctival fornices irrigated with 5 ml PI
1.25%. Conjunctiva cultures for aerobic and anaerobic bacteria will be obtained
(1) after general anaestheasia has been established, (2) 5-10 min after PI
irrigation, (3) after reattachment of the eye muscles and (4) after closing the
conjunctiva with sutures.
Study burden and risks
Risks are limited to the act of taking the four bacterial cultures, as both
1.25% PI and 5% PI are approved preoperative antiseptic applications of PI and
both are used, rather indiscriminately, by the university departments of
ophthalmology participating in the study.
Postbus 2040
3000 CA Rotterdam
NL
Postbus 2040
3000 CA Rotterdam
NL
Listed location countries
Age
Inclusion criteria
(1) Children < 6 years of age (2) undergoing surgery for strabismus for the first time, including any recession and/or resection surgery of the medial and/or lateral rectus muscles. (3) Children willing to take part in all aspects of the study and written informed consent on the study participation of the child provided by the parents.
Exclusion criteria
(1) Any history or current condition of hypersensitivity to iodine. (2) Children on topical antibiotic within the last 30 days. (3) Children with signs of acute conjunctivitis, blepharitis, dacryocystitis or respiratory infection within the last 30 days. (4) Children with asthma or similar chronic, obstructive pulmonary disorder (5) Insufficiently treated amblyopia, i.e. visual acuity must be equal in both eyes or not differ by more than 1 LogMAR line (or equivalent in preverbal children).
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
EudraCT | EUCTR2006-004811-22-NL |
CCMO | NL14357.000.07 |